Free Trial

Esperion Therapeutics (ESPR) Institutional Ownership

Esperion Therapeutics logo
$3.12 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$3.12 +0.00 (+0.16%)
As of 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Esperion Therapeutics (NASDAQ:ESPR)

Current
Institutional Ownership
Percentage
47.39%
Number of
Institutional Buyers
(last 12 months)
114
Total
Institutional Inflows
(last 12 months)
$190.74M
Number of
Institutional Sellers
(last 12 months)
35
Total
Institutional Outflows
(last 12 months)
$65.05M
Get ESPR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Esperion Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ESPR Institutional Buying and Selling by Quarter

Esperion Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Public Employees Retirement System of Ohio521,081$1.43M0.0%N/A0.202%
5/14/2026Sei Investments Co.116,229$318K0.0%+52.9%0.045%
5/14/2026Lido Advisors LLC99,139$272K0.0%N/A0.039%
5/14/2026State of Wyoming105,182$288K0.0%+66.0%0.041%
5/7/2026 Parallel Advisors LLC96,254$264K0.0%-9.8%0.037%
5/5/2026 Bank of New York Mellon Corp555,177$1.52M0.0%+1.1%0.216%
5/4/2026 Summit Wealth Group LLC405,369$1.11M0.3%+19.0%0.157%
5/4/2026 Principal Financial Group Inc.422,776$1.16M0.0%+53.0%0.164%
4/30/2026 Hsbc Holdings PLC48,141$132K0.0%+160.1%0.019%
4/30/2026 AIGH Capital Management LLC4,400,000$12.06M1.6%+10.0%1.709%
4/28/2026 Abel Hall LLC12,496$34K0.0%-56.8%0.005%
4/21/2026 Wasatch Advisors LP15,768,897$43.21M0.3%+66.9%6.126%
4/16/2026 SG Americas Securities LLC127,983$351K0.0%+151.0%0.050%
3/20/2026 Hsbc Holdings PLC18,510$70K0.0%N/A0.007%
3/3/2026 Caitong International Asset Management Co. Ltd36,744$136K0.0%+17.6%0.015%
2/19/2026 Invesco Ltd.765,118$2.83M0.0%+23.5%0.320%
2/18/2026Mackenzie Financial Corp336,992$1.24M0.0%+23.5%0.141%
2/18/2026XTX Topco Ltd161,974$599K0.0%N/A0.068%
2/18/2026nVerses Capital LLC67,450$250K0.6%N/A0.028%
2/18/2026Virtus Investment Advisers LLC177,508$657K0.2%N/A0.074%
2/18/2026Wellington Management Group LLP641,178$2.37M0.0%-5.9%0.268%
2/18/2026Quadrature Capital Ltd259,563$960K0.0%N/A0.109%
2/18/2026Orbimed Advisors LLC5,965,498$22.07M0.5%N/A2.495%
2/18/2026Millennium Management LLC3,932,274$14.55M0.0%+303.4%1.645%
2/18/2026Eversept Partners LP3,851,133$14.25M0.7%N/A1.611%
2/18/2026 ACT Capital Management LLC47,500$176K0.1%N/A0.020%
2/17/2026Schonfeld Strategic Advisors LLC75,238$278K0.0%N/A0.031%
2/17/2026Burkehill Global Management LP400,000$1.48M0.1%N/A0.167%
2/17/2026AQR Capital Management LLC290,514$1.08M0.0%+2.0%0.122%
2/17/2026 Abel Hall LLC28,943$107K0.0%+138.4%0.012%
2/17/2026Cetera Investment Advisers31,803$118K0.0%-47.7%0.013%
2/17/2026Lazard Asset Management LLC33,741$125K0.0%N/A0.014%
2/17/2026PenderFund Capital Management Ltd.4,391,926$16.25M2.6%-54.6%1.837%
2/17/2026Price T Rowe Associates Inc. MD188,639$698K0.0%+23.4%0.079%
2/17/2026Osaic Holdings Inc.86,443$320K0.0%+6.2%0.036%
2/17/2026 Russell Investments Group Ltd.21,573$80K0.0%-98.7%0.009%
2/17/2026Captrust Financial Advisors10,858$40K0.0%N/A0.005%
2/17/2026ExodusPoint Capital Management LP34,815$129K0.0%N/A0.015%
2/17/2026Royal Bank of Canada8,576$32K0.0%-99.1%0.004%
2/17/2026Graham Capital Management L.P.161,557$598K0.0%+968.9%0.068%
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
2/16/2026Mariner LLC278,661$1.03M0.0%-7.9%0.117%
2/16/2026Barclays PLC443,339$1.64M0.0%+32.1%0.185%
2/13/2026 Kestra Advisory Services LLC9,570$35K0.0%N/A0.004%
2/13/2026Marshall Wace LLP5,471,611$20.25M0.0%+117.0%2.289%
2/13/2026Hudson Bay Capital Management LP18,230$67K0.0%N/A0.008%
2/13/2026Rafferty Asset Management LLC61,045$226K0.0%+116.1%0.026%
2/13/2026Headlands Technologies LLC221,088$818K0.1%+129.7%0.092%
2/13/2026Velan Capital Investment Management LP1,210,000$4.48M2.6%N/A0.506%
2/13/2026Charles Schwab Investment Management Inc.715,326$2.65M0.0%+22.0%0.299%
2/13/2026State Street Corp5,930,296$21.94M0.0%+32.4%2.481%
2/13/2026 Wells Fargo & Company MN263,188$974K0.0%+80.4%0.110%
2/13/2026Summit Financial LLC107,263$397K0.0%+8.7%0.045%
2/12/2026 Wasatch Advisors LP9,445,759$34.95M0.2%+33.8%3.951%
2/12/2026HRT Financial LP239,360$885K0.0%+51.6%0.100%
2/12/2026MetLife Investment Management LLC129,735$480K0.0%+21.8%0.054%
2/12/2026Cibc World Markets Corp15,477$57K0.0%N/A0.006%
2/12/2026 Commonwealth Equity Services LLC23,009$85K0.0%+31.4%0.010%
2/12/2026 Tocqueville Asset Management L.P.107,000$396K0.0%+17.6%0.045%
2/12/2026Renaissance Technologies LLC2,194,600$8.12M0.0%+183.6%0.918%
2/12/2026EntryPoint Capital LLC23,500$87K0.0%N/A0.010%
2/12/2026Integrated Quantitative Investments LLC72,249$267K0.1%N/A0.030%
2/12/2026 New York State Common Retirement Fund63,900$236K0.0%+103.5%0.027%
2/12/2026Bank of Montreal Can51,923$192K0.0%+24.0%0.022%
2/12/2026Polen Capital Management LLC116,292$430K0.0%N/A0.049%
2/12/2026 Nuveen LLC3,612,113$13.37M0.0%-2.7%1.511%
2/11/2026 Deutsche Bank AG1,072,203$3.97M0.0%+805.4%0.449%
2/11/2026JPMorgan Chase & Co.965,059$3.57M0.0%+2.1%0.404%
2/11/2026 Los Angeles Capital Management LLC67,751$251K0.0%+40.6%0.028%
2/11/2026Two Seas Capital LP11,902,521$44.04M0.9%+22.1%4.979%
2/11/2026 WINTON GROUP Ltd58,345$216K0.0%-17.7%0.024%
2/11/2026 Parallel Advisors LLC106,684$395K0.0%-9.1%0.045%
2/11/2026State of Wyoming63,352$234K0.0%N/A0.027%
2/10/2026Goldman Sachs Group Inc.2,848,216$10.54M0.0%+66.7%1.191%
2/10/2026 Intech Investment Management LLC104,938$388K0.0%+5.5%0.044%
2/9/2026 Eaton Financial Holdings Company LLC46,595$172K0.0%+9.4%0.019%
2/9/2026PSI Advisors LLC22,344$83K0.0%+65.5%0.009%
2/9/2026Geode Capital Management LLC5,737,651$21.23M0.0%+20.8%2.400%
2/9/2026 Royce & Associates LP3,601,523$13.33M0.1%+57.0%1.507%
2/9/2026 Cary Street Partners Financial LLC10,175$38K0.0%N/A0.004%
2/6/2026Larson Financial Group LLC10,500$39K0.0%N/A0.004%
2/6/2026 ProShare Advisors LLC53,315$197K0.0%+29.0%0.022%
2/6/2026 Summit Wealth Group LLC340,606$1.26M0.3%+5.5%0.142%
2/6/2026 HighTower Advisors LLC113,899$421K0.0%-5.1%0.048%
2/4/2026 Versor Investments LP51,800$192K0.0%N/A0.022%
2/2/2026 AIGH Capital Management LLC4,000,000$14.80M3.6%+33.3%1.673%
1/30/2026 North Star Investment Management Corp.45,000$166K0.0%+28.6%0.019%
1/30/2026 R Squared Ltd15,173$56K0.0%+23.5%0.006%
1/29/2026Vanguard Group Inc.14,945,454$55.30M0.0%+23.6%6.252%
1/29/2026 China Universal Asset Management Co. Ltd.38,955$144K0.0%+10.2%0.016%
1/27/2026Round Rock Advisors LLC101,553$376K0.1%N/A0.042%
You're not getting into the SpaceX IPO. Do this instead. (Ad)

The SpaceX IPO is expected to price at $1.75 trillion - and retail investors won't get an allocation. Banks and insiders have already locked it up. But there is one small, publicly traded company that builds the critical infrastructure SpaceX cannot operate without. Dylan Jovine is releasing the ticker name today at no cost.tc pixel

Get the SpaceX backdoor ticker symbol before the market opens
1/26/2026 Mirae Asset Global Investments Co. Ltd.11,617$43K0.0%+49.0%0.005%
1/21/2026 KFG Wealth Management LLC10,000$37K0.0%N/A0.004%
1/21/2026 Capital Advisors Wealth Management LLC67,555$250K0.0%+58.7%0.028%
1/20/2026 Savvy Advisors Inc.60,000$222K0.0%N/A0.025%
1/12/2026Traynor Capital Management Inc.14,386$53K0.0%N/A0.006%
1/9/2026 SG Americas Securities LLC50,997$189K0.0%-50.8%0.021%
1/8/2026 Wealth Enhancement Advisory Services LLC28,338$105K0.0%+18.5%0.012%
1/1/2026JPMorgan Chase & Co.945,491$2.51M0.0%+68.4%0.396%
11/21/2025 CIBC Bancorp USA Inc.21,286$56K0.0%N/A0.009%
11/19/2025 Caitong International Asset Management Co. Ltd31,252$83K0.1%+40,487.0%0.013%


ESPR Institutional Ownership - Frequently Asked Questions

During the previous two years, 170 institutional investors and hedge funds held shares of Esperion Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($55.30M), Two Seas Capital LP ($44.04M), Wasatch Advisors LP ($43.21M), Bellevue Group AG ($26.65M), Orbimed Advisors LLC ($22.07M), State Street Corp ($21.94M), and Geode Capital Management LLC ($21.23M).Learn more on Esperion Therapeutics' institutional investors.

47.39% of Esperion Therapeutics' stock is owned by institutional investors. Learn more on ESPR's institutional investor holdings.

Of the 145 institutional investors that purchased Esperion Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wasatch Advisors LP ($16.33M), Marshall Wace LLP ($6.72M), Orbimed Advisors LLC ($5.97M), Bellevue Group AG ($5.74M), Two Seas Capital LP ($5.18M), AIGH Capital Management LLC ($4.40M), and Eversept Partners LP ($3.85M).

Institutional investors have bought a total of 61,723,253 shares in the last 24 months. This purchase volume represents approximately $190.74M in transactions.

Of the 34 institutional investors that sold Esperion Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: PenderFund Capital Management Ltd. ($5.28M), Two Seas Capital LP ($4.82M), Wasatch Advisors LP ($3.87M), Marshall Wace LLP ($2.79M), Russell Investments Group Ltd. ($1.69M), JPMorgan Chase & Co. ($1.36M), and Goldman Sachs Group Inc. ($1.23M).

Institutional investors have sold a total of 25,784,174 shares in the last 24 months. This volume of shares sold represents approximately $65.05M in transactions.



This page (NASDAQ:ESPR) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners